Toward greater adoption of minimally invasive and nephron-sparing surgical techniques for renal cell cancer in the United States-Reference-Cited by-同舟云学术

Toward greater adoption of minimally invasive and nephron-sparing surgical techniques for renal cell cancer in the United States

Published:2016-10 Issue:10 Volume:34 Page:433.e9-433.e17
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Banegas Matthew P.,Harlan Linda C.,Mann Bhupinder,Yabroff K. Robin

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference51 articles.

1. Howlader N, Noone AM, Krapacho M, et al. SEER Cancer Statistics Review, 1975-2012. 2015; http://seer.cancer.gov/csr/1975_2012/, based on November 2014 SEER data submission, posted to SEER website, April 2015.

2. Contemporary epidemiology of renal cell cancer;Chow;Cancer J,2008

3. Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Escudier;Ann Oncol,2014

4. EAU guidelines on renal cell carcinoma: the 2010 update;Ljungberg;Eur Urol,2010

5. Guideline for management of the clinical T1 renal mass;Campbell;J Urol,2009

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Outcomes Between Partial and Radical Laparoscopic Nephrectomy for Localized Renal Tumors Larger Than Four Centimeters: A Systematic Review and Meta-Analysis;World Journal of Oncology;2024-08

2. Development and External Validation of Nomograms for Predicting Disease-Free Survival and Overall Survival in Patients with cT1-ccRCC After Partial Nephrectomy: A Multicenter Retrospective Study;Annals of Surgical Oncology;2024-07-06

3. Trends and Costs of Minimally Invasive Surgery for Kidney Cancer in the US: A Population-based Study;Urology;2024-07

4. Outcomes and Techniques of Robotic-Assisted Partial Nephrectomy (RAPN) for Renal Hilar Masses: A Comprehensive Systematic Review;Cancers;2024-02-06

5. Predicting adverse outcomes in oncological nephrectomy: let’s take a look at the patient around the tumor;Translational Andrology and Urology;2023-01